Literature DB >> 19823767

Nitric oxide synthase 1 and cyclooxygenase-2 enzymes are targets of muscarinic activation in normal and inflamed NIH3T3 cells.

A J Español1, N Goren, M L Ribeiro, María Elena Sales.   

Abstract

OBJECTIVE: Fibroblasts are sentinel cells that could serve as intermediaries in the immune reaction in the inflammatory process. In this work, we investigate the action of the muscarinic agonist carbachol (CARB) on the expression and function of nitric oxide synthase (NOS) and cyclooxygenase (COX) in fibroblasts under normal or inflammatory conditions.
METHODS: The normal fibroblast cell line, 3T3, from NIH swiss mouse embryo, was used. The inflammatory milieu was mimicked with lipopolysaccharide (LPS) (10 ng/ml) plus interferon gamma (IFNgamma) (0.5 ng/ml). Nitric oxide (NO) and prostaglandin E(2) (PGE(2)) production were measured by Griess reagent and radioimmunoassay, respectively. NOS, COX, and nuclear transcription factor kappa B (NF-kappaB) were studied by Western blot.
RESULTS: CARB increased NO synthesis by 57 +/- 5%, while a 150 +/- 10% increase in NO liberation was triggered by LPS plus IFNgamma treatment. CARB added to LPS plus IFNgamma potentiated NO synthesis by 227 +/- 19%. CARB also upregulated NOS1 protein expression via NF-kappaB activation. In addition CARB and LPS plus IFNgamma stimulated PGE(2) synthesis by 72 +/- 9 and 42 +/- 4%, respectively, while CARB added to LPS plus IFNgamma treated cells produced a synergism in PGE(2) liberation (130 +/- 12%) via COX-2.
CONCLUSION: Activation of muscarinic acetylcholine receptors can mimic mild inflammatory conditions or can deepen pre-existing inflammation, establishing a fine-tuned set-up on fibroblasts that in turn could be alerting the immune system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19823767     DOI: 10.1007/s00011-009-0097-4

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  39 in total

Review 1.  Lymphocyte trafficking and regional immunity.

Authors:  E C Butcher; M Williams; K Youngman; L Rott; M Briskin
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

Review 2.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

3.  Nitric oxide synthase-cyclooxygenase interactions are involved in tumor cell angiogenesis and migration.

Authors:  L Davel; A D'Agostino; A Español; M A Jasnis; L Lauría de Cidre; E S de Lustig; M E Sales
Journal:  J Biol Regul Homeost Agents       Date:  2002 Jul-Sep       Impact factor: 1.711

Review 4.  Regulation of cyclooxygenase enzymes by nitric oxide.

Authors:  D Salvemini
Journal:  Cell Mol Life Sci       Date:  1997-07       Impact factor: 9.261

Review 5.  G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.

Authors:  Christopher C Fraser
Journal:  Int Rev Immunol       Date:  2008       Impact factor: 5.311

6.  Novel insight into the mechanisms involved in the regulation of the m1 muscarinic receptor, iNOS and nNOS mRNA levels.

Authors:  Leonor Sterin-Borda; Sabrina Ganzinelli; Alejandro Berra; Enri Borda
Journal:  Neuropharmacology       Date:  2003-08       Impact factor: 5.250

7.  Mechanism of interferon-gamma-induced increase in T84 intestinal epithelial tight junction.

Authors:  Michel A Boivin; Praveen K Roy; Angela Bradley; John C Kennedy; Tuhama Rihani; Thomas Y Ma
Journal:  J Interferon Cytokine Res       Date:  2009-01       Impact factor: 2.607

8.  Parasympathetic modulation of local acute inflammation in murine submandibular glands.

Authors:  Alejandro J Español; Eulalia de la Torre; María Elena Sales
Journal:  Inflammation       Date:  2003-04       Impact factor: 4.092

9.  Transient up-regulation of spinal cyclooxygenase-2 and neuronal nitric oxide synthase following surgical inflammation.

Authors:  Sharron Dolan; James G Kelly; Marie Huan; Andrea M Nolan
Journal:  Anesthesiology       Date:  2003-01       Impact factor: 7.892

10.  Soluble CD14 participates in the response of cells to lipopolysaccharide.

Authors:  E A Frey; D S Miller; T G Jahr; A Sundan; V Bazil; T Espevik; B B Finlay; S D Wright
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  6 in total

1.  Treatment with LPS plus INF-γ induces the expression and function of muscarinic acetylcholine receptors, modulating NIH3T3 cell proliferation: participation of NOS and COX.

Authors:  A J Español; M O Maddaleno; M G Lombardi; M Cella; P Martínez Pulido; M E Sales
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

2.  Primary cilia elongation in response to interleukin-1 mediates the inflammatory response.

Authors:  A K T Wann; M M Knight
Journal:  Cell Mol Life Sci       Date:  2012-04-06       Impact factor: 9.261

3.  Analysis of the ways and methods of signaling pathways in regulating cell cycle of NIH3T3 at transcriptional level.

Authors:  Cuifang Chang; Zhipeng Niu; Ningning Gu; Weiming Zhao; Gaiping Wang; Yifeng Jia; Deming Li; Cunshuan Xu
Journal:  BMC Cell Biol       Date:  2015-10-28       Impact factor: 4.241

4.  Protective Effect of Strawberry Extract against Inflammatory Stress Induced in Human Dermal Fibroblasts.

Authors:  Massimiliano Gasparrini; Tamara Y Forbes-Hernandez; Francesca Giampieri; Sadia Afrin; Bruno Mezzetti; Josè L Quiles; Stefano Bompadre; Maurizio Battino
Journal:  Molecules       Date:  2017-01-21       Impact factor: 4.411

5.  A comparative analysis of the photo-protective effects of soy isoflavones in their aglycone and glucoside forms.

Authors:  Barbara Iovine; Maria Luigia Iannella; Franco Gasparri; Valentina Giannini; Giuseppe Monfrecola; Maria Assunta Bevilacqua
Journal:  Int J Mol Sci       Date:  2012-12-04       Impact factor: 5.923

6.  Functional enhancement of AT1R potency in the presence of the TPαR is revealed by a comprehensive 7TM receptor co-expression screen.

Authors:  Jonas Tind Hansen; Christina Lyngsø; Tobias Speerschneider; Pernille B L Hansen; Céline Galés; David M Weiner; Søren P Sheikh; Ethan S Burstein; Jakob Lerche Hansen
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.